A program for the optimization of cyclosporine therapy using population kinetics modeling

Computer Methods and Programs in Biomedicine

Volumn 61, Issue 1, 2000, Pages 61-69

  Ruggeri, A ^a   Martinelli, M ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Bayesian estimation; Cyclosporine therapy; Mathematical modeling; Population kinetics

Indexed keywords

ALGORITHMS; COMPUTER SIMULATION; DRUG DOSAGE; ESTIMATION; GRAPHICAL USER INTERFACES; MATHEMATICAL MODELS;

BAYESIAN ESTIMATION; CYCLOSPORINE THERAPY;

MEDICAL COMPUTING;

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; BAYES THEOREM; COMPARTMENT MODEL; COMPUTER PROGRAM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MATHEMATICAL MODEL; ORGAN TRANSPLANTATION; POPULATION DYNAMICS; SIMULATION;

ALGORITHMS; BAYES THEOREM; CYCLOSPORINE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; KINETICS; MODELS, BIOLOGICAL; SOFTWARE;

EID: 0033990640     PISSN: 01692607     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-2607(99)00028-0     Document Type: Article

References (19)

1. Bennett W.M. Clinical algorithms for cyclosporine management based on pathophysiologic constructs of nephrotoxicity. Transplant. Proc. 26:1994;2583-2584.
2. Best N.G., Tan K.K.C., Trull A.K., Spiegelhalter D.J., Hue K.L., Caine N., Wallwork J. Design and evaluation of a computer tool to aid early management of cyclosporine therapy after heart and heart-lung transplantation. Transplant. Proc. 26:1994;2716-2717.
3. Kahan B.D., Kramer W.G., Williams C., Wideman C.A. Application of Bayesian forecasting to predict appropriate cyclosporine dosing regimens for renal allograft recipients. Transplant. Proc. 18:1986;200-203.
4. Kahan B.D., Kramer W.G., Wideman C., Flechner S.M., Lorber M.I., Van Buren C.T. Demographic factors affecting the pharmacokinetics of cyclosporine estimated by radioimmunoassay. Transplantation. 41:1986;459-464.
5. Kahan B.D. Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters. Transplantation. 40:1985;457-476.
6. Jelliffe R.W., Schumitzky A., Van Guilder M., Liu M., Hu L., Marie P., Gomis P., Barbaut X., Tahani B. Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive control. Ther. Drug Monit. 15:1993;380-393.
7. Grevel J., Nüesch E., Abisch E., Kutz K. Pharmacokinetics of oral cyclosporin A (Sandimmun) in healthy subject. Eur. J. Clin. Pharmacol. 31:1986;211-216.
8. Niven A.A., Grevel J., Al-Banna M. et al. Pharmacokinetics of cyclosporine in the early-post operative period following renal transplantation. Br. J. Clin. Pharmacol. 26:1988;626P-627P.
9. Bréant V., Charpiat B., Sab J.M., Maire P., Jelliffe R.W. How many patients and blood level are necessary for population pharmacokinetic analysis? Eur. J. Clin. Pharmacol. 51:1996;283-288.
10. E.R. Carson, C. Cobelli, L. Finkelstein, The mathematical modeling of metabolic and endocrine systems, Wiley-Interscience, New York, 1983.
11. M. Davidian, D.M. Giltinan, Nonlinear models for repeated measurement data, Chapman & Hall, London, 1995.
12. Steimer J.L., Mallet A., Golmard J.L., Boisvieux J.F. Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effects model. Drug Metab. Rev. 15:1984;265-292.
13. M. Davidian, A.R. Gallant, Nlmix: a program for maximum likelihood estimation of the nonlinear mixed effects model with a smooth random effects density. User's Guide.
14. ftp://ftp.econ.duke.edu/home/arg/nlmix.
15. Davidian M., Gallant A.R. Smooth nonparametric maximum likelihood estimation for population parmacokinetics, with application to quinidine. J. Pharmacokin. Biopharm. 20:1992;529-556.
16. Davidian M., Gallant A.R. The nonlinear mixed effects model with a smooth random effects density. Biometrika. 80:1993;475-488.
17. D.Z. D'Argenio, A. Schumitzky, ADAPT II. User's guide to Release 4, Biomedical Simulations Resource, University of Southern California, LA, 1997.
18. http://www.usc.edu/dept/biomed/BMSR/Software/adptmenu.html.
19. Anderson J.E., Munday A.S., Kelman A.W. Evaluation of Bayesian approach to the pharmacokinetics interpretation of cyclosporine concentrations in renal allograft patients. Ther. Drug Monit. 16:1994;160-165.